Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BEAM Beam Therapeutics Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $24.67 +6.8% | $15.37 -0.2% |
| StockIQ Score | 38F Weak Risk: High | 35F Weak Risk: High |
| Technical | 19F | 13F |
| Fundamental | 30F | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 38F | 38F |
| News | 32F | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
BEAM scores higher than AAPG on the investor (38 vs 35), technical (19 vs 13) and growth (68 vs 50) metrics. AAPG leads in the fundamental score (35 vs 30). Both stocks share the same valuation score of 38.